CO6460780A2 - Péptido - Google Patents
PéptidoInfo
- Publication number
- CO6460780A2 CO6460780A2 CO11156774A CO11156774A CO6460780A2 CO 6460780 A2 CO6460780 A2 CO 6460780A2 CO 11156774 A CO11156774 A CO 11156774A CO 11156774 A CO11156774 A CO 11156774A CO 6460780 A2 CO6460780 A2 CO 6460780A2
- Authority
- CO
- Colombia
- Prior art keywords
- peptide
- present
- provides
- hemophilia
- ednimvtfrnqasr
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102100026735 Coagulation factor VIII Human genes 0.000 abstract 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 2
- 108010054218 Factor VIII Proteins 0.000 abstract 1
- 102000001690 Factor VIII Human genes 0.000 abstract 1
- 201000003542 Factor VIII deficiency Diseases 0.000 abstract 1
- 208000009292 Hemophilia A Diseases 0.000 abstract 1
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 abstract 1
- 108010027412 Histocompatibility Antigens Class II Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 208000013633 acquired hemophilia Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229960000301 factor viii Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0908515.0A GB0908515D0 (en) | 2009-05-18 | 2009-05-18 | Peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6460780A2 true CO6460780A2 (es) | 2012-06-15 |
Family
ID=40834163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11156774A CO6460780A2 (es) | 2009-05-18 | 2011-11-17 | Péptido |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8703705B2 (enExample) |
| EP (2) | EP2465523B1 (enExample) |
| JP (1) | JP5784009B2 (enExample) |
| KR (1) | KR101673889B1 (enExample) |
| CN (1) | CN102458445B (enExample) |
| AU (1) | AU2010250957B2 (enExample) |
| BR (1) | BRPI1012845A2 (enExample) |
| CA (1) | CA2762020C (enExample) |
| CL (1) | CL2011002893A1 (enExample) |
| CO (1) | CO6460780A2 (enExample) |
| CY (1) | CY1115832T1 (enExample) |
| DK (1) | DK2465523T3 (enExample) |
| EA (1) | EA027229B1 (enExample) |
| EC (1) | ECSP11011540A (enExample) |
| ES (1) | ES2525448T3 (enExample) |
| GB (1) | GB0908515D0 (enExample) |
| HR (1) | HRP20141182T1 (enExample) |
| IL (1) | IL216199A (enExample) |
| MX (1) | MX2011012270A (enExample) |
| MY (1) | MY168207A (enExample) |
| NZ (2) | NZ613713A (enExample) |
| PL (1) | PL2465523T3 (enExample) |
| PT (1) | PT2465523E (enExample) |
| RS (1) | RS53671B1 (enExample) |
| SG (2) | SG190573A1 (enExample) |
| SI (1) | SI2465523T1 (enExample) |
| SM (1) | SMT201400186B (enExample) |
| UA (1) | UA110921C2 (enExample) |
| WO (1) | WO2010133834A2 (enExample) |
| ZA (1) | ZA201108446B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX353233B (es) | 2009-12-06 | 2018-01-08 | Bioverativ Therapeutics Inc | Polipéptidos híbridos y quiméricos del factor viii-fc, y métodos de uso de los mismos. |
| PL2917232T3 (pl) * | 2012-11-12 | 2017-09-29 | Apitope International Nv | Pochodzące od czynnika VIII peptydy do zastosowania w leczeniu hemofilii A |
| GB201314052D0 (en) * | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| PE20231949A1 (es) | 2015-10-30 | 2023-12-05 | Spark Therapeutics Inc | VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA |
| WO2018102743A1 (en) | 2016-12-02 | 2018-06-07 | Bioverativ Therapeutics Inc. | Methods of treating hemophilic arthropathy using chimeric clotting factors |
| RS66972B1 (sr) | 2018-05-18 | 2025-07-31 | Bioverativ Therapeutics Inc | Metode lečenja hemofilije a |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1311542T1 (sl) | 2000-08-21 | 2009-02-28 | Apitope Technology Bristol Ltd | Tolerogenski peptidi |
| US20040096456A1 (en) * | 2000-12-01 | 2004-05-20 | Conti-Fine Bianca M | Method to treat hemophilia |
| AU2002312660A1 (en) * | 2001-05-31 | 2002-12-16 | D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| WO2002096454A1 (en) | 2001-05-31 | 2002-12-05 | D. Collen Research Foundation Vzw | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| JP2005538694A (ja) * | 2002-04-18 | 2005-12-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 修飾されたｖｉｉｉ因子 |
| GB0723712D0 (en) * | 2007-12-04 | 2008-01-16 | Apitope Technology Bristol Ltd | Peptides |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
-
2009
- 2009-05-18 GB GBGB0908515.0A patent/GB0908515D0/en not_active Ceased
-
2010
- 2010-05-17 UA UAA201114970A patent/UA110921C2/uk unknown
- 2010-05-17 SI SI201030819T patent/SI2465523T1/sl unknown
- 2010-05-17 BR BRPI1012845A patent/BRPI1012845A2/pt not_active IP Right Cessation
- 2010-05-17 KR KR1020117028276A patent/KR101673889B1/ko not_active Expired - Fee Related
- 2010-05-17 MX MX2011012270A patent/MX2011012270A/es active IP Right Grant
- 2010-05-17 EA EA201171430A patent/EA027229B1/ru not_active IP Right Cessation
- 2010-05-17 NZ NZ613713A patent/NZ613713A/en not_active IP Right Cessation
- 2010-05-17 MY MYPI2011005515A patent/MY168207A/en unknown
- 2010-05-17 AU AU2010250957A patent/AU2010250957B2/en not_active Ceased
- 2010-05-17 NZ NZ596300A patent/NZ596300A/xx not_active IP Right Cessation
- 2010-05-17 PL PL12159740T patent/PL2465523T3/pl unknown
- 2010-05-17 DK DK12159740.5T patent/DK2465523T3/en active
- 2010-05-17 WO PCT/GB2010/000997 patent/WO2010133834A2/en not_active Ceased
- 2010-05-17 ES ES12159740.5T patent/ES2525448T3/es active Active
- 2010-05-17 EP EP12159740.5A patent/EP2465523B1/en active Active
- 2010-05-17 CA CA2762020A patent/CA2762020C/en not_active Expired - Fee Related
- 2010-05-17 US US13/320,201 patent/US8703705B2/en not_active Expired - Fee Related
- 2010-05-17 CN CN201080032337.0A patent/CN102458445B/zh not_active Expired - Fee Related
- 2010-05-17 SG SG2013030713A patent/SG190573A1/en unknown
- 2010-05-17 JP JP2012511336A patent/JP5784009B2/ja not_active Expired - Fee Related
- 2010-05-17 EP EP10721533A patent/EP2432494A2/en not_active Withdrawn
- 2010-05-17 PT PT121597405T patent/PT2465523E/pt unknown
- 2010-05-17 SG SG2011084985A patent/SG176138A1/en unknown
- 2010-05-17 RS RS20140660A patent/RS53671B1/sr unknown
-
2011
- 2011-11-07 IL IL216199A patent/IL216199A/en not_active IP Right Cessation
- 2011-11-17 ZA ZA2011/08446A patent/ZA201108446B/en unknown
- 2011-11-17 CO CO11156774A patent/CO6460780A2/es active IP Right Grant
- 2011-11-17 CL CL2011002893A patent/CL2011002893A1/es unknown
- 2011-12-16 EC EC2011011540A patent/ECSP11011540A/es unknown
-
2014
- 2014-12-06 HR HRP20141182AT patent/HRP20141182T1/hr unknown
- 2014-12-15 SM SM201400186T patent/SMT201400186B/xx unknown
- 2014-12-17 CY CY20141101057T patent/CY1115832T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010327A (es) | Péptidos del fviii y su uso para hemofílicos tolerantes | |
| CO6460780A2 (es) | Péptido | |
| EA201270313A1 (ru) | Композиции, которые индуцируют хелперное действие т-клеток | |
| IN2012DN02368A (enExample) | ||
| ECSP13012436A (es) | ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
| CY1115999T1 (el) | Νεα και ισχυρα mhc- κατηγοριας ιι πεπτιδια που προερχονται απο σουρβιβινη και νευροκανη | |
| EA201992536A1 (ru) | Tcr и пептиды | |
| EA201100268A1 (ru) | Вакцина | |
| MX2017004559A (es) | Receptores de celulas t. | |
| CO6470802A2 (es) | Péptido auxiliar del antígeno del cáncer | |
| ES2691091T3 (es) | Vacuna conjugada de péptido antigénico de WT1 | |
| UA103751C2 (ru) | Иммуногенный пептид для иммунотерапии | |
| MX337456B (es) | Vacunas peptidicas para canceres que expresan antigenos asociados con tumores. | |
| MX2016002937A (es) | Vacuna oncologica. | |
| PE20160778A1 (es) | Peptidos | |
| EA200701305A1 (ru) | Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида | |
| AR094275A1 (es) | COMPOSICION INMUNOGENICA QUE COMPRENDE LA PROTEINA CDTb DE CLOSTRIDIUM DIFFICILE | |
| PE20191617A1 (es) | Peptidos y combinaciones de peptidos para el uso en la inmunoterapia contra la leucemia y otros tipos de cancer | |
| BR112015010625A2 (pt) | Peptídeos | |
| CL2021001479A1 (es) | Péptido; uso de composiciones; composición farmacéutica; uso de un anticuerpo para terapia; uso de un anticuerpo para elisa, inmunohistoquímica y/o formación de imágenes; receptor de linfocito t; y uso de un linfocito t citotóxico activado (divisional de la solicitud n° 201701391) | |
| EA201390811A1 (ru) | Пептиды tomm34 и содержащие их вакцины | |
| BR112013009276A2 (pt) | peptídeos de c18orf54 e vacinas incluindo os mesmos | |
| TH130487A (th) | เพปไทด์ที่อนุพัทธ์มาจากแฟคเตอร์ viii | |
| UA114015C2 (xx) | Пептид | |
| CY1117265T1 (el) | Αντισωματα aνti-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted |